Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04923321
Other study ID # 18936
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 22, 2021
Est. completion date May 7, 2021

Study information

Verified date February 2022
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Determine the taste intensity at supra-threshold among a sample of depressed Egyptian adults (age from 20 to 50 years old) under anti-depressants therapy ( for at least 3 months) using filter paper disc(FPD) method using a psychophysical method through a scoring system.


Description:

PECO - P Population: depressed Egyptian adults under anti-depressants therapy - E1 Exposure 1: Tricyclic antidepressants (Imipramine, Amitriptyline, Clomipramine HCL) - E2 Exposure 2: Selective Serotonin Re-uptake inhibitors antidepressants ( Fluoxetine, Fluvoxamine, Sertraline, Citalopram, Paroxetine) - C control (non exposure) : non-pharmacological treatment ( psychotherapy) - O Outcome: Determine the taste intensity at supra-threshold among these patients using a psychophysical method through a scoring system


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 7, 2021
Est. primary completion date April 8, 2021
Accepts healthy volunteers No
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: - Depressed Egyptian adults under antidepressants therapy for at least 3 months/non-pharmacological treatment( psychotherapy) • Age from 20 to 50 years old Exclusion Criteria: - Antipsychotics - Hypnotics - Anticonvulsants - Ages other than the mentioned • Olfactory dysfunction - Chemosensory dysfunction

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Egypt Faculty of Dentistry, Cairo University Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Taste intensity at supra-threshold - C.M will assess the taste intensity at supra-threshold level on a 9 point vertical labeled scale (extremely strong, very strong, strong, slightly strong, neutral, slightly weak, weak , very weak, extremely weak) in which subjects indicate the intensity perceived when tasting a substance during a period of 3 months from February 2021 till April 2021]
See also
  Status Clinical Trial Phase
Completed NCT04532632 - Taste and Smell Impairment in Critically Ill COVID-19 Patients
Completed NCT04145453 - Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults N/A
Recruiting NCT02931812 - Feeding Behavior and Taste Sensitivity Before and After Liver or Renal Transplantation
Not yet recruiting NCT04661800 - Study of Olfactory Disorders in Patients With Cardiac Amyloidosis N/A
Completed NCT04302792 - New Food Solutions for Cancer Patients N/A
Withdrawn NCT05760079 - Lactoferrin for COVID-19-Induced Taste or Smell Abnormality N/A
Completed NCT03196440 - Sensitivity of Basic Taste in Elderly
Completed NCT04235153 - CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients
Recruiting NCT02304913 - Hypoglossal Acupuncture for Dysgeusia in Patients Undergoing Chemotherapy N/A
Recruiting NCT04881513 - The Change of the Structure and Function of Taste Buds After the Otosclerosis Surgery N/A
Completed NCT04543175 - Taste Disorders and Their Relation to BMI, FFQ, and EORTC QLQ-BR23 in Breast Cancer Patients During Chemotherapy.
Completed NCT03599011 - Gustatory Dysfunction Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
Completed NCT04923425 - Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
Completed NCT03498950 - Changes in Sense of Taste of Patients Submitted to Hematopoietic Stem Cell Transplantation N/A
Withdrawn NCT03043144 - Taste And Smell TEsting in End Stage Renal Disease N/A
Recruiting NCT06456008 - Prospective Registery of Smell/Taste Clinic Ear/Nose/Throat
Not yet recruiting NCT05104424 - The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions Phase 1
Completed NCT01540045 - Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Completed NCT05227157 - GOUTMETALSAIN: Comparison of the Perception of Metallic Taste According to Lingual Locations in Healthy Volunteers
Completed NCT00316563 - Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study Phase 2